SMMT logo

Summit Therapeutics (SMMT) Cash from investing

annual CFI:

-$205.34M+$382.43M(+65.06%)
December 31, 2024

Summary

  • As of today (June 19, 2025), SMMT annual cash flow from investing activities is -$205.34 million, with the most recent change of +$382.43 million (+65.06%) on December 31, 2024.
  • During the last 3 years, SMMT annual CFI has fallen by -$205.03 million (-67004.90%).
  • SMMT annual CFI is now -13925.81% below its all-time high of $1.49 million, reached on January 31, 2006.

Performance

SMMT Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTcash flow metrics

quarterly CFI:

$160.11M+$76.63M(+91.79%)
March 31, 2025

Summary

  • As of today (June 19, 2025), SMMT quarterly cash flow from investing activities is $160.11 million, with the most recent change of +$76.63 million (+91.79%) on March 31, 2025.
  • Over the past year, SMMT quarterly CFI has increased by +$140.24 million (+705.75%).
  • SMMT quarterly CFI is now at all-time high.

Performance

SMMT quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTcash flow metrics

TTM CFI:

-$65.10M+$140.24M(+68.30%)
March 31, 2025

Summary

  • As of today (June 19, 2025), SMMT TTM cash flow from investing activities is -$65.10 million, with the most recent change of +$140.24 million (+68.30%) on March 31, 2025.
  • Over the past year, SMMT TTM CFI has dropped by -$142.26 million (-184.37%).
  • SMMT TTM CFI is now -184.37% below its all-time high of $77.16 million, reached on March 31, 2024.

Performance

SMMT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSMMTcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SMMT Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+65.1%+705.8%-184.4%
3 y3 years-10000.0%+10000.0%-10000.0%
5 y5 years-10000.0%+10000.0%-10000.0%

SMMT Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%+65.1%at high+124.8%-184.4%+90.0%
5 y5-year<-9999.0%+65.1%at high+124.8%-184.4%+90.0%
alltimeall time<-9999.0%+65.1%at high+124.8%-184.4%+90.0%

SMMT Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$160.11M(+91.8%)
-$65.10M(-68.3%)
Dec 2024
-$205.34M(-65.1%)
$83.48M(-176.9%)
-$205.34M(-10.0%)
Sep 2024
-
-$108.61M(-45.7%)
-$228.25M(+85.4%)
Jun 2024
-
-$200.08M(-1106.9%)
-$123.13M(-259.6%)
Mar 2024
-
$19.87M(-67.2%)
$77.16M(-113.1%)
Dec 2023
-$587.77M(>+9900.0%)
$60.57M(-1837.5%)
-$587.77M(-9.3%)
Sep 2023
-
-$3.49M(-1784.1%)
-$648.33M(+0.5%)
Jun 2023
-
$207.00K(-100.0%)
-$644.83M(-0.1%)
Mar 2023
-
-$645.06M(<-9900.0%)
-$645.33M(>+9900.0%)
Dec 2022
-$624.00K(+103.9%)
$10.00K(-50.0%)
-$624.00K(-17.2%)
Sep 2022
-
$20.00K(-106.8%)
-$754.00K(-2.1%)
Jun 2022
-
-$293.00K(-18.8%)
-$770.00K(+22.6%)
Mar 2022
-
-$361.00K(+200.8%)
-$628.00K(+105.2%)
Dec 2021
-$306.00K(-27.3%)
-$120.00K(-3100.0%)
-$306.00K(+29.7%)
Sep 2021
-
$4000.00(-102.6%)
-$236.00K(-16.9%)
Jun 2021
-
-$151.00K(+287.2%)
-$284.00K(+6.8%)
Mar 2021
-
-$39.00K(-22.0%)
-$266.00K(-36.8%)
Dec 2020
-$421.00K(+23.5%)
-
-
Dec 2020
-
-$50.00K(+13.6%)
-$421.00K(+13.5%)
Sep 2020
-
-$44.00K(-66.9%)
-$371.00K(+3.1%)
Jun 2020
-
-$133.00K(-31.4%)
-$359.80K(-26.1%)
Mar 2020
-
-$194.00K(+491.5%)
-$486.90K(-11.9%)
Dec 2019
-$341.00K(+3.0%)
-
-
Oct 2019
-
-$32.80K(-87.4%)
-$552.80K(+5.5%)
Jul 2019
-
-$260.10K(>+9900.0%)
-$524.10K(+78.4%)
Apr 2019
-
-$2600.00(-99.0%)
-$293.70K(-11.3%)
Jan 2019
-$331.00K
-
-
Jan 2019
-
-$257.30K(+6175.6%)
-$331.00K(-95.3%)
Oct 2018
-
-$4100.00(-86.2%)
-$6.97M(-0.7%)
Jul 2018
-
-$29.70K(-25.6%)
-$7.02M(-1.1%)
DateAnnualQuarterlyTTM
Apr 2018
-
-$39.90K(-99.4%)
-$7.10M(-4.3%)
Jan 2018
-$7.42M(+7319.9%)
-
-
Jan 2018
-
-$6.90M(>+9900.0%)
-$7.42M(+1181.1%)
Oct 2017
-
-$56.60K(-46.5%)
-$579.20K(+8.0%)
Jul 2017
-
-$105.80K(-70.7%)
-$536.20K(+17.9%)
Apr 2017
-
-$360.80K(+544.3%)
-$454.90K(+355.4%)
Jan 2017
-$100.00K(+94.9%)
-
-
Jan 2017
-
-$56.00K(+311.8%)
-$99.90K(+142.5%)
Oct 2016
-
-$13.60K(-44.5%)
-$41.20K(-40.4%)
Jul 2016
-
-$24.50K(+322.4%)
-$69.10K(+65.7%)
Apr 2016
-
-$5800.00(-314.8%)
-$41.70K(-18.7%)
Jan 2016
-$51.30K(-312.9%)
-
-
Jan 2016
-
$2700.00(-106.5%)
-$51.30K(-12.6%)
Oct 2015
-
-$41.50K(-1531.0%)
-$58.70K(+1530.6%)
Jul 2015
-
$2900.00(-118.8%)
-$3600.00(-117.6%)
Apr 2015
-
-$15.40K(+227.7%)
$20.50K(-14.9%)
Jan 2015
$24.10K(-77.2%)
-
-
Jan 2015
-
-$4700.00(-134.6%)
$24.10K(-16.3%)
Oct 2014
-
$13.60K(-49.6%)
$28.80K(+89.5%)
Jul 2014
-
$27.00K(-328.8%)
$15.20K(-228.8%)
Apr 2014
-
-$11.80K
-$11.80K
Jan 2014
$105.60K(-202.8%)
-
-
Jan 2013
-$102.70K(-40.5%)
-
-
Jan 2012
-$172.70K(+1.1%)
-
-
Jan 2011
-$170.90K(+48.6%)
-
-
Jan 2010
-$115.00K(-90.5%)
-
-
Jan 2009
-$1.22M(-19.8%)
-
-
Jan 2008
-$1.52M(-34.8%)
-
-
Jan 2007
-$2.32M(-256.4%)
-
-
Jan 2006
$1.49M(-105.7%)
-
-
Jan 2005
-$26.00M
-
-

FAQ

  • What is Summit Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Summit Therapeutics?
  • What is Summit Therapeutics annual CFI year-on-year change?
  • What is Summit Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Summit Therapeutics?
  • What is Summit Therapeutics quarterly CFI year-on-year change?
  • What is Summit Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Summit Therapeutics?
  • What is Summit Therapeutics TTM CFI year-on-year change?

What is Summit Therapeutics annual cash flow from investing activities?

The current annual CFI of SMMT is -$205.34M

What is the all time high annual CFI for Summit Therapeutics?

Summit Therapeutics all-time high annual cash flow from investing activities is $1.49M

What is Summit Therapeutics annual CFI year-on-year change?

Over the past year, SMMT annual cash flow from investing activities has changed by +$382.43M (+65.06%)

What is Summit Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of SMMT is $160.11M

What is the all time high quarterly CFI for Summit Therapeutics?

Summit Therapeutics all-time high quarterly cash flow from investing activities is $160.11M

What is Summit Therapeutics quarterly CFI year-on-year change?

Over the past year, SMMT quarterly cash flow from investing activities has changed by +$140.24M (+705.75%)

What is Summit Therapeutics TTM cash flow from investing activities?

The current TTM CFI of SMMT is -$65.10M

What is the all time high TTM CFI for Summit Therapeutics?

Summit Therapeutics all-time high TTM cash flow from investing activities is $77.16M

What is Summit Therapeutics TTM CFI year-on-year change?

Over the past year, SMMT TTM cash flow from investing activities has changed by -$142.26M (-184.37%)
On this page